Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Renal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00030342
What this trial is testing

Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer

Who this might be right for
Colorectal CancerKidney Cancer
St. Luke's Medical Center 60
Testing effectiveness (Phase 2)Ended earlyNCT01372813
What this trial is testing

Vandetanib to Treat Advanced Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Carcinoma
National Cancer Institute (NCI) 3
Not applicableStudy completedNCT00088803
What this trial is testing

DNA Variations in the Gene in Young Patients With Wilms' Tumor

Who this might be right for
Kidney Cancer
Children's Oncology Group 471
Testing effectiveness (Phase 2)Study completedNCT00006486
What this trial is testing

Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Recurrent Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 335
Not applicableLooking for participantsNCT05060783
What this trial is testing

Renal Cancer Detection With Liquid Biopsy

Who this might be right for
Renal CancerOncocytoma
Zealand University Hospital 200
Early research (Phase 1)Looking for participantsNCT07300241
What this trial is testing

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell CarcinomaRenal Cell CarcinomaRCC+6 more
Neomorph, Inc 30
Not applicableStudy completedNCT04006405
What this trial is testing

AURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Elypta 280
Testing effectiveness (Phase 2)Study completedNCT03581773
What this trial is testing

Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy

Who this might be right for
MucositisStomatitis
Niels Fristrup 84
Testing effectiveness (Phase 2)Study completedNCT03149822
What this trial is testing

Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
University of Colorado, Denver 45
Not applicableStudy completedNCT00080873
What this trial is testing

Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Children's Oncology Group 195
Testing effectiveness (Phase 2)Study completedNCT01510119
What this trial is testing

Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Abramson Cancer Center at Penn Medicine 40
Early research (Phase 1)Study completedNCT04504669
What this trial is testing

First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

Who this might be right for
Clear Cell Renal Cell CancerNon-Small-Cell Lung CancerTriple Negative Breast Neoplasms+6 more
AstraZeneca 60
Not applicableStudy completedNCT04213157
What this trial is testing

Laparoscopic Partial Nephrectomy for cT1 Tumors

Who this might be right for
Renal CancerRenal NeoplasmRenal Cell Carcinoma+10 more
Samsun Liv Hospital 292
Early research (Phase 1)Study completedNCT00016237
What this trial is testing

Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Bladder CancerKidney CancerLung Cancer
EMD Serono
Not applicableLooking for participantsNCT05403177
What this trial is testing

Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

Who this might be right for
Breast CancerColorectal CancerPancreas Cancer+9 more
University Health Network, Toronto 500
Early research (Phase 1)Study completedNCT00056537
What this trial is testing

ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer

Who this might be right for
Non-Small-Cell Lung CarcinomaRenal Cell CarcinomaPancreatic Cancer
Active Biotech AB 44
Early research (Phase 1)Looking for participantsNCT05536141
What this trial is testing

AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaSolid Tumors
Arcus Biosciences, Inc. 362
Testing effectiveness (Phase 2)Looking for participantsNCT07223541
What this trial is testing

Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
University of Oklahoma 72
Not applicableStudy completedNCT02228954
What this trial is testing

IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC)

Who this might be right for
Clear-cell Metastatic Renal Cell CarcinomaKidney Neoplasms
Radboud University Medical Center 40
Not applicableUnknownNCT03694912
What this trial is testing

Development and Evaluation of High Risk Group Prediction Model in T1 Stage Renal Cell Cancer Using Molecular Biomarkers

Who this might be right for
Clear Renal Cell Cancer (< 7cm Size)
Yonsei University 426
Next Page